25 Mar, 2019
Cardiac Marker Dialogues Meeting Sponsorship
We are delighted to let you know that we are sponsoring the 4th Cardiac Marker Dialogues meeting in April.
Read more
27 Feb, 2019
Come to Meet our Team at CACLP, China
We will attend the 16th China Association of Clinical Laboratory Practice Expo held at Nanchang Greenland International Expo Center, on 22-24 March.
Read more
18 Dec, 2018
Season's Greetings
We would like to wish you immense happiness during this holiday season and throughout the coming year.
Read more
29 Nov, 2018
New MAbs Specific to Canine Parvovirus (CPV)
We have included three new anti-CPV antibodies to our offering. These new MAbs work well in different pair combinations demonstrating high sensitivity in sandwich immunoassays.
Read more
27 Nov, 2018
Come to Meet our Team at VMX 2019
We will be present at the VMX: Veterinary Meeting & Expo, Orlando during January 19-23.
Read more
31 Oct, 2018
NEW! Recombinant Feline SAA Protein
Serum amyloid A is used as an inflammatory marker in different animals. In cats, it is the only biomarker that shows a rapid and significant response to inflammation.
Read more
30 Oct, 2018
Call for Nominations - Sponsoring EFLM Award
We are delighted to let you know that we are sponsoring the EFLM-HyTest Cardiac Marker Award for remarkable scientific work in the field of cardiovascular diseases.
Read more
22 Oct, 2018
Meet us at Medica Exhibition in November
If you or your colleagues will attend the MEDICA 2018 - the World's Leading Medical Forum - from November 12 to 15, in Düsseldorf, Germany, please schedule a meeting with us.
Read more
25 Sep, 2018
HyTest Supports Cancer Research
HyTest supports cancer research and families burdened with the disease
Read more
06 Sep, 2018
Summa Equity Acquires Finnish Antibody Manufacturer HyTest
Summa Equity will become majority shareholder of the Finnish company HyTest, producer of antibodies and antigens for the diagnostic industry.
Read more
30 Aug, 2018
HyTest Revenue Growth Fueled by Sales in China
During the first half of the year, HyTest’s consolidated revenue grew to 14.4 million euros.
Read more
29 Aug, 2018
Podcast: cTnI and its Proteolytic Fragments in Blood
Our latest article on cardiac troponin I was recently published in Clinical Chemistry. Now you can listen...
Read more
04 Jul, 2018
HyTest posters at Heart Failure 2018
Our researchers presented two posters at the Heart Failure Congress 2018
Read more
04 Jul, 2018
Lp-PLA2 Audioslides
Watch our presentation of this biomarker to learn more.
Read more
11 Jun, 2018
Meet us at AACC 2018 in Chicago
We will be participating the 2018 AACC Annual Meeting & Clinical Lab Expo. The exhibition will be on July 31 - August 2 in Chicago.
Read more
30 May, 2018
New HyTest Introduction Video - We are HyTest
Are you familiar with all of our different clinical areas? Or were you already aware of how many products we are able to manufacture and ship to our customers every year?
Read more
30 May, 2018
Anti-cTnT MAbs with Negligible Cross-Reactivity to Skeletal Troponin T
In high-sensitivity troponin assays, the specificity of the antibodies utilized is of utmost importance. As the clinically relevant concentration of cardiac troponin T is just nanograms per litre, even a minor cross-reactivity of the assay to skeletal troponin T isoforms could result in false positives.
Read more
26 Apr, 2018
Growth Continues - High Growth of Sales in China
During the last fiscal year HyTest’s consolidated revenue was 24.1 million euros, which equated to a year-on-year growth of 1.3%. This rate was low due to the exceptionally strong growth experienced in 2016.
Read more
24 Apr, 2018
Articles from HyTest Scientists - Receive a Free Copy!
An integral part of research is made up of the articles that are published in peer-reviewed journals. This year, three different studies conducted by our R&D team have already been published...
Read more

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!